Trends in the Treatment of Anemia Using Recombinant Human Erythropoietin in Patients with HIV Infection
{{output}}
Background: Treating anemia with erythropoietin (EPO) to hemoglobin (Hb) endpoints >11 g/dL may increase risk of serious adverse cardiovascular events. Methods: ... ...
